Literature DB >> 2988761

Suppression of tumor promoter-induced chemiluminescence in mouse epidermal cells by several inhibitors of arachidonic acid metabolism.

S M Fischer, L M Adams.   

Abstract

The tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) is a stimulator of chemiluminescence (CL) in SENCAR mouse epidermal cells. The CL response is TPA dose dependent (8 to 800 nM) as well as proportional to the number of cells used. Treatment with 166 nM TPA results in a CL response that peaks by 15 min although a strong response persists for over 30 min. The CL response can be inhibited by superoxide dismutase and the superoxide dismutase mimetic copper(II) (3,4 diisopropylsalicylic acid)2, suggesting that the CL response may be due to or mediated by superoxide anions. Catalase, which is specific for H2O2, and mannitol, which is a scavenger for hydroxyl radicals, had negligible inhibitory effects. The CL response is also inhibited by retinoic acid and the analogue ethyl all-trans-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8- nonatetraenoate. A series of phorbol esters with different promoting abilities produced corresponding CL responses. The second stage tumor promoter mezerein is as effective as TPA in stimulating CL. Inhibitors of various parts of the arachidonic acid cascade were found to affect the TPA-induced CL response in a manner that corresponds to their effects in vivo tumor promotion experiments: agents which are predominantly lipoxygenase inhibitors, i.e., nordihydroguaiaretic acid, benoxaprofen, or agents which are effective against both lipoxygenase or cyclooxygenase, i.e., 5,8,11,14-eicosatetraynoic acid and phenidone, are effective in diminishing the CL response. Cyclooxygenase inhibitors, i.e., indomethacin and flurbiprofen, have no or a slight enhancing effect at low doses. These data suggest that at least a major part of the TPA-induced CL response is due to the metabolism of arachidonic acid, most probably by the lipoxygenase(s). This CL assay may provide a useful system for studying the involvement of oxidants in tumor promotion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988761

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Reactive oxygen intermediates involved in cellular regulation.

Authors:  B Meier
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

2.  Role of activation of protein kinase C in the stimulation of colonic epithelial proliferation and reactive oxygen formation by bile acids.

Authors:  P A Craven; J Pfanstiel; F R DeRubertis
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

3.  Role of reactive oxygen in bile salt stimulation of colonic epithelial proliferation.

Authors:  P A Craven; J Pfanstiel; F R DeRubertis
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

4.  CD18/ICAM-1-dependent oxidative NF-kappaB activation leading to nitric oxide production in rat Kupffer cells cocultured with syngeneic hepatoma cells.

Authors:  I Kurose; H Saito; S Miura; H Ebinuma; H Higuchi; N Watanabe; S Zeki; T Nakamura; M Takaishi; H Ishii
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

5.  Reactive oxygen in the tumor promotion stage of skin carcinogenesis.

Authors:  S M Fischer; G S Cameron; J K Baldwin; D W Jasheway; K E Patrick
Journal:  Lipids       Date:  1988-06       Impact factor: 1.880

6.  Protection against chemically-induced oxidative gastrointestinal tissue injury in rats by bismuth salts.

Authors:  D Bagchi; O R Carryl; M X Tran; M Bagchi; P J Vuchetich; R L Krohn; S D Ray; S Mitra; S J Stohs
Journal:  Dig Dis Sci       Date:  1997-09       Impact factor: 3.199

7.  In vitro effects of a smokeless tobacco extract on the production of reactive oxygen species by human oral epidermal cells and rat hepatic mitochondria and microsomes, and peritoneal macrophages.

Authors:  M Bagchi; D Bagchi; S J Stohs
Journal:  Arch Environ Contam Toxicol       Date:  1996-03       Impact factor: 2.804

8.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.

Authors:  R Schreck; B Meier; D N Männel; W Dröge; P A Baeuerle
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.